Proyectos

Antigen development by 3D bioprinting involves using bio-inks composed of cells and biomaterials to create tissue-like structures that can produce antigens. This technology enables precise modeling of human tissues for vaccine development, disease study, and personalized immunotherapy, offering a scalable method to produce targeted antigens for medical research and treatment.

Vaccine development using CRISPR involves leveraging the gene-editing technology to enhance the immune response or engineer cells that produce targeted antigens. CRISPR can be used to modify pathogens or immune cells to create more effective, precise, and personalized vaccines, potentially speeding up development and improving vaccine efficacy against various diseases, including viruses and cancer.

Antivenom sera production using stem cells involves harnessing the regenerative capabilities of stem cells to create immune cells or tissues that produce antibodies against venom toxins. This approach can offer a scalable, controlled method to generate antivenom, reducing reliance on traditional animal-based production and improving safety, effectiveness, and accessibility of antivenom treatments.